Half-Year Financial Results 2022

Half-Year Financial Results 2022

We are pleased with the continued growth we have generated so far this financial year given the challenging environments we faced from ongoing lockdowns. Our strategic focus on targeting large-scale clients, while selectively investing for growth, has enabled us to grow revenues sustainably. We will continue to run lean and look to execute on our backlog of projects as people return to work and site access resumes. Our clinical business remains robust as we continue to grow our relationship with Medtronic and look forward to progressing this partnership further during the second half of the year. The investment in targeting top-tier clients and leveraging our channel partnership strategy has led to our sales pipeline being as strong as ever, and I am excited by the future opportunity.
Dr Andrew Ronchi, dorsaVi’s Chief Executive Officer

Please click the below links to read the documents:
ASX Release Announcement 22 Feb 2022
ASX Release 4D Half Year Report 22 Feb 2022

Request Info